Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Cancer

Cracking glioblastoma core regulatory codes

Glioblastoma (GBM) heterogeneity might arise because of the activation of various gene core regulatory circuitries (CRCs). A new study highlights the central role of HOXB3 in GBM CRCs and how peptide-mediated perturbation of HOXB3-related CRCs in GBM holds potential as treatment for a subset of patients.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: CRC-driven GBM heterogeneity as a therapeutic target.

References

  1. Price, B. et al. Neuro-Oncol. 26, iii1–iii85 (2024).

    Article  PubMed  PubMed Central  Google Scholar 

  2. Xie, T. et al. Nat. Commun. 15, 3905 (2024).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Patel, A. P. et al. Science 344, 1396–1401 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Eisenbarth, D. & Wang, Y. A. Oncogene 42, 2155–2165 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Neftel, C. et al. Cell 178, 835–849 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Zhang, C. et al. Nat. Cell Biol. https://doi.org/10.1038/s41556-025-01758-y (2025).

    Article  PubMed  PubMed Central  Google Scholar 

  7. Schaffner, W. Biol. Chem. 396, 311–327 (2015).

    Article  CAS  PubMed  Google Scholar 

  8. Hnisz, D. et al. Cell 155, 934–947 (2013).

    Article  CAS  PubMed  Google Scholar 

  9. Chen, Y. et al. Oncogene 39, 6633–6646 (2020).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wu, S. J. et al. Nat. Biotechnol. 39, 819–824 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Bartosovic, M., Kabbe, M. & Castelo-Branco, G. Nat. Biotechnol. 39, 825–835 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Saint-André, V. et al. Genome Res. 26, 385–396 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

  13. Sabari, B. R. et al. Science 361, eaar3958 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lu, B. et al. Adv. Sci. 8, 2101895 (2021).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

G.C.-B. was supported by the Swedish Research Council (Distinguished Professor grant 2023-00324), the Swedish Cancer Society (Cancerfonden grant 232945 Pj 01 H) and the Knut and Alice Wallenberg Foundation (Wallenberg Scholar grant 2023-0280). Y.D was supported by a Swedish Cancer Society postdoctoral grant.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Gonçalo Castelo-Branco.

Ethics declarations

Competing interests

G.C.-B. is a shareholder and board member at Nexus Epigenomics. The other authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dang, Y., Lor, Y.K. & Castelo-Branco, G. Cracking glioblastoma core regulatory codes. Nat Cell Biol 27, 1600–1602 (2025). https://doi.org/10.1038/s41556-025-01780-0

Download citation

  • Published:

  • Version of record:

  • Issue date:

  • DOI: https://doi.org/10.1038/s41556-025-01780-0

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer